Back

Long-term toxicity of radiosurgery for ablation of ventricular tachycardia

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Interventional treatment for ventricular tachycardia in structural heart disease: new approaches for better outcome? Radiotherapy ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Mr Jakub Cvek

University Hospital Ostrava, Ostrava (Czechia)

3 More presentations in this session

Presentation thumbnail
Post-infarct VT substrate ablation based on evoked delayed potential elimination as well-defined target: results from a prospective multicenter study.
Doctor M. De Riva Silva (Leiden, NL)
Abstract Slides Video
Presentation thumbnail
Anatomical-based percutaneous left stellate ganglion block in patients with refractory electrical storm: efficacy and safety.
Doctor S. Compagnoni (Pavia, IT)
Abstract Slides Video
Presentation thumbnail
Stellate ganglion blockade for treatment of ventricular arrhythmia storm: A meta-analysis
Doctor S. Zafeiropoulos (Zurich, CH)
Abstract Slides Video

Access the full session

Session thumbnail
Interventional treatment for ventricular tachycardia in structural heart disease: new approaches for better outcome?

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022
You may be interested in
thumbnail
Congress Presentation
A ventricular tachycardia case not treatable with transcatheter ablation due to apical thrombosis of the left ventricle resolved with radiotherapy based on the non-invasive mapping system
thumbnail
Congress Presentation
When to go beyond guidelines for VT management ? – A STAR is born
thumbnail
Congress Presentation
Radiosurgery for ventricular tachycardia (RAVENTA): Final results of a German multicenter multiplatform feasibility trial

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources